Gonadotropin-releasing factor en es it fr

Gonadotropin-releasing factor Brand names, Gonadotropin-releasing factor Analogs

Gonadotropin-releasing factor Brand Names Mixture

  • No information avaliable

Gonadotropin-releasing factor Chemical_Formula

(FeO.OH.2H2O)478 (Dx.COOH)9

Gonadotropin-releasing factor RX_link

http://www.rxlist.com/cgi/generic3/fedex.htm

Gonadotropin-releasing factor fda sheet

Gonadotropin-releasing factor msds (material safety sheet)

Gonadotropin-releasing_factor MSDS

Gonadotropin-releasing factor Synthesis Reference

No information avaliable

Gonadotropin-releasing factor Molecular Weight

105000 g/mol (average)

Gonadotropin-releasing factor Melting Point

No information avaliable

Gonadotropin-releasing factor H2O Solubility

Soluble

Gonadotropin-releasing factor State

Solid

Gonadotropin-releasing factor LogP

No information avaliable

Gonadotropin-releasing factor Dosage Forms

Solution (for intramuscular injection)

Gonadotropin-releasing factor Indication

For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.

Gonadotropin-releasing factor Pharmacology

Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.

Gonadotropin-releasing factor Absorption

The major portion of intramuscular injections of iron dextran is absorbed within 72 hours; most of the remaining iron is absorbed over the ensuing 3 to 4 weeks.

Gonadotropin-releasing factor side effects and Toxicity

LD50 = 500 mg/kg (mouse, IV). Dosages of iron dextran in excess of the requirements for restoration of hemoglobin and replenishment of iron stores may lead to hemosiderosis. Cases of severe, sometimes fatal, allergic reactions (loss of consciousness, collapse, difficulty breathing, hives, swelling, or convulsions) and severe low blood pressure (hypotension) have been reported with the use of iron dextran.

Gonadotropin-releasing factor Patient Information

http://www.drugs.com/cons/Inulin.html

Gonadotropin-releasing factor Organisms Affected

Humans and other mammals